Novartis and Sandoz Recognized in UK and Europe by Top Employers Institute
Novartis UK and the company's division, Sandoz UK, today announced that they have been officially certified by the Top Employers Institute for their “exceptional employee offerings both within the UK and throughout Europe”. Novartis UK has been consistently recognized for its dedication to employees in the UK and Europe. It is the second year in a row that Sandoz UK has been certified as a UK and Europe Top Employer. The Top Employers Institute is a global certification company that recognizes excellence in the conditions that employers create for their people. The Institute assessed the employee offerings of Novartis UK and Sandoz UK based on the following criteria:
• Talent strategy ⨠• Workforce planning ⨕ On-boarding⨠• Learning and development⨠• Performance management⨠• Leadership development ⨕ Career and succession management⨠• Compensation and benefits⨠• Culture David Plink, CEO of the Top Employers Institute, commented: “Optimal employee conditions ensure that people can develop themselves personally and professionally. Our comprehensive research concluded that Novartis UK and Sandoz UK both provide outstanding employment environments and offer a wide range of creative initiatives, from secondary benefits and working conditions, to performance-management programmes that are well thought out and truly aligned with the culture of their company.”
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.
